Effects of apalutamide dose reduction on skin‐related adverse events in patients with advanced prostate cancer: A multicenter retrospective study
出版年份 2022 全文链接
标题
Effects of apalutamide dose reduction on skin‐related adverse events in patients with advanced prostate cancer: A multicenter retrospective study
作者
关键词
-
出版物
PROSTATE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-10-31
DOI
10.1002/pros.24453
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy of combined androgen blockade therapy in patients with metastatic hormone‐sensitive prostate cancer stratified by tumor burden
- (2022) Yoshiyuki Nagumo et al. INTERNATIONAL JOURNAL OF UROLOGY
- Effect of upfront combination therapy on the overall survival of patients with metastatic castration‐sensitive prostate cancer: A multicenter retrospective study
- (2022) Toshikazu Tanaka et al. INTERNATIONAL JOURNAL OF UROLOGY
- Low Body Weight as a Risk Factor for Apalutamide-related Cutaneous Adverse Events
- (2022) MICHIE KATSUTA et al. ANTICANCER RESEARCH
- Efficacy and safety exposure–response relationships of apalutamide in patients with metastatic castration-sensitive prostate cancer: results from the phase 3 TITAN study
- (2022) Huybrecht T’jollyn et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Impact of body size on skin‐related adverse events in advanced prostate cancer treated with apalutamide: A multicenter retrospective study
- (2022) Daichi Sasaki et al. INTERNATIONAL JOURNAL OF UROLOGY
- Safety and efficacy of apalutamide in Japanese patients with metastatic castration‐sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo‐controlled, phase III TITAN study
- (2022) Hirotsugu Uemura et al. INTERNATIONAL JOURNAL OF UROLOGY
- Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium
- (2022) Yoichiro Tohi et al. International Journal of Clinical Oncology
- Treatment strategies and outcomes in a long‐term registry study of patients with high‐risk metastatic hormone‐naïve prostate cancer in Japan: An interim analysis of the J‐ROCK study
- (2022) Hirotsugu Uemura et al. INTERNATIONAL JOURNAL OF UROLOGY
- Predictive factors of survival outcomes in first‐line therapy for metastatic castration‐resistant prostate cancer
- (2021) Masaki Shiota et al. INTERNATIONAL JOURNAL OF UROLOGY
- Useful predictors of progression‐free survival for Japanese patients with LATITUDE‐high‐risk metastatic castration‐sensitive prostate cancer who received upfront abiraterone acetate
- (2021) Kiyoshi Takahara et al. INTERNATIONAL JOURNAL OF UROLOGY
- Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study
- (2020) Hiroji Uemura et al. Prostate International
- Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study
- (2020) Hiroji Uemura et al. BMC Urology
- Apalutamide for metastatic, castration‐sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double‐blind, placebo‐controlled phase 3 TITAN study
- (2020) Hirotsugu Uemura et al. INTERNATIONAL JOURNAL OF UROLOGY
- Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
- (2019) Karim Fizazi et al. LANCET ONCOLOGY
- Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
- (2019) Kim N. Chi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology of prostate cancer in Asian countries
- (2018) Takahiro Kimura et al. INTERNATIONAL JOURNAL OF UROLOGY
- Clinical and molecular features of treatment-related neuroendocrine prostate cancer
- (2018) Shusuke Akamatsu et al. INTERNATIONAL JOURNAL OF UROLOGY
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
- (2018) Christos E. Kyriakopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer
- (2018) Masaki Shiota et al. INTERNATIONAL JOURNAL OF UROLOGY
- Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition)
- (2017) Yoshiyuki Kakehi et al. INTERNATIONAL JOURNAL OF UROLOGY
- Current treatment strategies for advanced prostate cancer
- (2017) Kazumasa Komura et al. INTERNATIONAL JOURNAL OF UROLOGY
- Recent Trends in PSA Testing and Prostate Cancer Incidence
- (2016) Ruth Etzioni et al. JAMA Oncology
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started